Recurrent Candidemia: Trends and Risk Factors Among Persons Residing in 4 US States, 2011–2018

Abstract

Abstract Background Candidemia is a common healthcare-associated infection with high mortality. Estimates of recurrence range from 1% to 17%. Few studies have focused on those with recurrent candidemia, who often experience more severe illness and greater treatment failure. We describe recurrent candidemia trends and risk factors. Methods We analyzed population-based candidemia surveillance data collected during 2011–2018. Persons with >1 episode (defined as the 30-day period after a positive Candida species) were classified as having recurrent candidemia. We compared factors during the initial episode between those who developed recurrent candidemia and those who did not. Results Of the 5428 persons identified with candidemia, 326 (6%) had recurrent infection. Recurrent episodes occurred 1.0 month to 7.6 years after any previous episode. In multivariable logistic regression controlling for surveillance site and year, recurrent candidemia was associated with being 19–44 years old (vs ≥65 years; adjusted odds ratio [aOR], 3.05 [95% confidence interval {CI}, 2.10–4.44]), being discharged to a private residence (vs medical facility; aOR, 1.53 [95% CI, 1.12–2.08]), hospitalization in the 90 days prior to initial episode (aOR, 1.66 [95% CI, 1.27–2.18]), receipt of total parenteral nutrition (aOR, 2.08 [95% CI, 1.58–2.73]), and hepatitis C infection (aOR, 1.65 [95% CI, 1.12–2.43]). Conclusions Candidemia recurrence >30 days after initial infection occurred in >1 in 20 persons with candidemia. Associations with younger age and hepatitis C suggest injection drug use may play a modifiable role. Prevention efforts targeting central line care and total parenteral nutrition use may help reduce the risk of recurrent candidemia.